Difference between actual and published PK parameters [Study As­sess­ment]

posted by Loky do – Egypt, 2022-02-15 14:20 (1238 d 01:32 ago) – Posting: # 22783
Views: 4,376

Thanks Helmut for your reply ;-), excuse my confusion, I have a question regarding dapoxetine biphasic half-life; the initial and terminal half-life (the initial half-life which is 1.3-1.5 hours and the terminal half-life which is 15-19 hours) does this biphasic nature affect the practical obtained half life of the drug? and is this nature could affect the drug variability?

Thanks

Complete thread:

UA Flag
Activity
 Admin contact
23,428 posts in 4,929 threads, 1,680 registered users;
59 visitors (0 registered, 59 guests [including 16 identified bots]).
Forum time: 16:52 CEST (Europe/Vienna)

No matter what side of the argument you are on,
you always find people on your side
that you wish were on the other.    Thomas Berger

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5